Related references
Note: Only part of the references are listed.Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Enhanced Nitric Oxide Release and Reduced Blood Pressure and sICAM-1 Levels in Hypertensive Rats
R. Preston Mason et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Nebivolol Exerts Beneficial Effects on Endothelial Function, Early Endothelial Progenitor Cells, Myocardial Neovascularization, and Left Ventricular Dysfunction Early After Myocardial Infarction Beyond Conventional β1-Blockade
Sajoscha A. Sorrentino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Basal Release of ATP: An Autocrine-Paracrine Mechanism for Cell Regulation
Ross Corriden et al.
SCIENCE SIGNALING (2010)
Advances in Pharmacologic Modulation of Nitric Oxide in Hypertension
Yoshiko Mizuno et al.
Current Cardiology Reports (2010)
Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of β-Blockers
R. Preston Mason et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Nebivolol, a Vasodilating Selective β1-Blocker, Is a β3-Adrenoceptor Agonist in the Nonfailing Transplanted Human Heart
Bertrand Rozec et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease
Yoshiko Mizuno et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity
R. Preston Mason et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans
RP Mason et al.
CIRCULATION (2005)
Exploring vascular benefits of endothelium-derived nitric oxide
JR Cockcroft
AMERICAN JOURNAL OF HYPERTENSION (2005)
Endothelial β3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation β-blocker nebivolol
C Dessy et al.
CIRCULATION (2005)
The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery
A Georgescu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation β-blocker
LJ Ignarro
BLOOD PRESSURE (2004)
Third-generation β-blockers stimulate nitric oxide release from endothelial cells through ATP efflux -: A novel mechanism for antihypertensive action
L Kalinowski et al.
CIRCULATION (2003)
Nebivolol prevents vascular NOSIII uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells
H Mollnau et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin
L Kalinowski et al.
CIRCULATION (2002)
Nebivolol reverses endothelial dysfunction in essential hypertension - A randomized, double-blind, crossover study
N Tzemos et al.
CIRCULATION (2001)
Cyclic GMP-dependent relaxation of isolated rat renal glomeruli induced by extracellular ATP
M Jankowski et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Share Paper
